Anti-microbial peptides

2:

• The peptide of claim 1, wherein said peptide comprises the amino acid sequence RRRWWWWX (SEQ ID NO:
• 62), wherein X is any amino acid.

3:

• The peptide of claim 2, wherein X is leucine, valine, or alanine.

4:

• The peptide of claim 1, wherein said peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 56-59.

5:

• A peptide comprising the sequence GLLSLLSLLGKLL (SEQ ID NO:
• 1), wherein at least one amino acid has been substituted, inserted, and/or deleted, or said peptide comprises the amino acids of GLLSLLSLLGKLL (SEQ ID NO:
• 1) in a shuffled sequence.

6:

• The peptide of claim 5, wherein the peptide comprises the sequence GLLSLLSLLGKLL (SEQ ID NO:
• 1), wherein at least one amino acid has been substituted and/or deleted.

7:

• The peptide of claim 6, wherein at least one of the leucine amino acids at positions 5, 6, 8, 9, 12, or 13 has been substituted and/or deleted.

8:

• The peptide of claim 5, wherein said peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 2-15 and 18 or wherein said peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 22-28.

9:

• A peptide comprising the sequence GLSLLLSLGLKLL (SEQ ID NO:
• 23), wherein at least one amino acid has been substituted, inserted, and/or deleted, and wherein the sequence LLL is retained.

10:

• The peptide of claim 9, wherein said peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 29-34.

11:

• A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
• 42-48.

12:

• The peptide of claim 1, wherein said peptide comprises at least one D-amino acid.

13:

• The peptide of claim 12, wherein all of the amino acids are D-amino acids.

14:

• The peptide of claim 1, wherein said peptide comprises at least one modification selected from the group consisting of amidation and acetylation.

15:

• The peptide of claim 1, wherein said peptide is less than 12 amino acids in length.

16:

• A composition comprising at least one peptide of claim 1 and at least one pharmaceutically acceptable carrier.

17:

• The composition of claim 16, further comprising at least one antibiotic.

18:

• A method for inhibiting a microbial infection in a subject in need thereof, said method comprising administering to said subject at least one peptide of claim 1.

19:

• The method of claim 18, further comprising the administration of at least one additional antibiotic.

20:

• The method of claim 18, wherein said microbial infection is a staphylococcal infection.

21:

• The method of claim 18, wherein said microbial infection is a methicillin-resistant Staphylococcus aureus (MRSA) infection.

22:

• A medical device or implant comprising at least one peptide of claim 1 covalently attached to the surface of the medical device or implant.